WKN DE: A14UQC / ISIN: FR0012333284

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Abivax Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)
15:35:36	104,300	302
15:33:44	104,200	329
15:33:35	103,900
15:18:30	105,100
15:03:14	104,800
14:33:39	105,600
14:18:54	105,200
13:50:58	106,100
13:31:14	106,100
13:16:31	105,700
13:01:25	106,200
12:51:12	106,200
12:31:25	106,200
12:16:20	106,400
12:01:27	106,600
11:31:50	107,000
11:16:46	106,700
11:01:59	106,700
10:32:03	106,500
10:20:41	106,300
10:16:57	106,500
10:02:11	106,500
09:32:21	107,200
09:27:55	106,800	227
09:15:20	106,300
09:06:19	107,200
08:56:08	106,900
08:32:46	107,000
08:17:53	106,900
08:04:43	107,100
07:53:43	107,100
07:37:46	108,500
07:32:49	108,100

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Nachrichten zu Abivax SA

30.07.26		EQS-News: Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
23.07.26		EQS-News: Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
02.07.26		EQS-News: Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
01.07.26		EQS-News: Abivax announces trading resumption of its ordinary shares on Euronext Paris
01.07.26		EQS-News: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
01.07.26		EQS-News: Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
30.06.26		Rally im Biotech-Sektor: Abivax-Aktie hebt nach positivem Obefazimod-Update ab
01.06.26		EQS-News: Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Analysen zu Abivax SA

Weitere Meldungen

15:15		678 Billion Reasons to Invest in Microsoft Stock
15:10		Company Insider Sells $560,000 of Financial Stock in Tax-Driven Transaction, According to Latest SEC Filing
15:06		JPMorgan says Warsh failure to buttress Fed credibility may force a rate hike before year-end
15:02		Oelkers kommt aus Schweden: Biontech findet Nachfolger für Gründer Sahin
15:00		KI-Update kompakt: KI-Investitionen, Forschungssoftware, iCloud+, GEMA vs. Suno
15:00		Why Apple's AI Strategy Looks Different From Everyone Else's
14:51		Chevron vs. ExxonMobil: Which Dividend Compounds Better Over the Next 10 Years?
14:50		TotalEnergies Boosts Clean Energy Growth With Shell Deal
14:42		Why Is Bristol-Myers Squibb Stock Surging Monday?
14:41		Constellation Energy vs. Vistra: Which Utilities Stock Is a Better Buy in 2026?
14:38		Microsoft Pays Cash. Amazon Borrows. Here's How Big Tech Funds Its AI Boom.
14:37		Microsoft and Amazon Won the AI Spending Week. Alphabet, Meta, and Oracle Didn't. Now What?
14:34		Shangri-La Profit Accelerates In H1 As China Market Rebounds
14:34		Eli Lilly Could Swing Over $76 Billion In Value After Earnings
14:30		Seagate Technology Is Soaring After Its Strong Earnings Report. Should You Buy Western Digital Before Its Earnings Report?
14:27		Jim Cramer Senses a 'Fake Out' in Rumored AstraZeneca, Bristol Myers Squibb $400 Billion Mega-Merger
14:25		Lendlease Global Commercial Reit posts 3% rise in H2 DPU to S$0.0185
14:20		Sandisk Stock Is Falling Monday: What's Going On?
14:16		Snowflake To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
14:15		Jeff Bezos Is Poised to Add Billions More to His Fortune as Amazon Stock Extends Massive Rally After a $25 Billion Windfall
14:11		Gary Black Says Investors Shouldn't 'Fall in Love' With TSLA Stock, Calls Out 'Cult' Mentality for Attacking Those Who Questions Elon Musk-Led Company
14:10		Amazon.com vs. CAVA: Which Consumer Stock Is a Better Buy in 2026, the Veteran E-Commerce Giant or Rising Restaurant Chain?
14:09		Boeing Stock Is Gaining Monday: What's Going On?
14:08		1 Unstoppable Stock to Buy Before It Joins Nvidia, Alphabet, Apple, and Microsoft in the $3 Trillion Club
14:06		Which Is the Better International ETF: Vanguard's Low-Cost VEA or State Street's Climate-Focused NZAC?
14:05		SLB, Target, Transocean And A Tech Stock Stock On CNBC’s ‘Final Trades’
14:03		Amazon.com vs. Airbnb: Comparing Revenue Trends Between an E-Commerce Leader and a Travel Giant
14:01		AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
14:00		Bernie Sanders, Ben McKenzie Slam CLARITY Act as a Handout to Crypto's 'Gambling' Industry
14:00		heise-Angebot: iX-Workshop: Fit für die Zukunft - Software im laufenden Betrieb modernisieren
13:58		Singapore shares fall as local banks end mixed; STI down 0.3%
13:57		LyondellBasell Analysts Boost Their Forecasts After Upbeat Q2 Earnings
13:55		How To Earn $500 A Month From Caterpillar Stock Ahead Of Q2 Earnings
13:53		ArcelorMittal Expands Microsoft Partnership To Accelerate AI-Led Digital Transformation
13:52		Caterpillar's Order Backlog Hit a Record $63 Billion. Will Tuesday's Report Show AI Power Demand Still Filling It?
13:51		Trump’s ‘Perimeter of a Deal’ Rallies the Market
13:49		Diamond buyers are freaking out in Vietnam after gem scandal
13:45		Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
13:30		Top Wall Street Forecasters Revamp Clorox Expectations Ahead Of Q4 Earnings
13:26		Jamie Dimon Just Made a Bold Call on the Future of the Stock Market. History Says Investors Should Make This 1 Move
13:25		Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?
13:25		AI Data Centers Keep Minting Money for IES Holdings
13:24		The gap between big tech and the rest of the market just vanished. Here’s what it means for investors.
13:21		DBS names former Ping An chief innovation officer Jonathan Larsen to board
13:15		Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks With Over 5% Dividend Yields
13:15		GameStop Stock Slips on Dilution Concerns - Here's Why
13:15		If Wall Street Is Wrong About AI, Would Oklo Still Be Worth Buying?
13:12		This Eaton Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
13:07		Oracle Inks 10-Year, $7 Billion Contract With DoD -- What Investors Need to Know
13:05		Apac Realty H1 net profit falls 16.8% to S$9.4 million; special divided of S$0.036 a share proposed

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Graham Holdings BCP Finance Newera Resources Flying Monkey Capital The Babcock & Wilcox

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	03.08.2026 15:55
Kaufwert:	EUR
	Hinzufügen Speichern

Abivax Aktie

WKN DE: A14UQC / ISIN: FR0012333284

Abivax Times and Sales (STU)

Nachrichten zu Abivax SA

Analysen zu Abivax SA

Weitere Meldungen